Assyro AI

Orange Book product · Brand (NDA)

DOPTELET SPRINKLE

AVATROMBOPAG MALEATE

Brand (NDA)NDA 219696RX AKARX INC

At a glance

Jul 24, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 24, 2025

    11 mo ago

  2. Today

  3. Patent 7638536 expires

    Listed drug substance patent expiration.

    Jul 28, 2027

    in 1 yr 1 mo

  4. Exclusivity ends · NP

    New product exclusivity (3 years)

    Jul 24, 2028

    in 2 yr 2 mo

  5. Exclusivity ends · ODE-548

    Orphan-drug exclusivity (7 years)

    Jul 24, 2032

    in 6 yr 2 mo

Pharmaceutical detail

Active ingredient

AVATROMBOPAG MALEATE

Strength

EQ 10MG BASE

Dosage form

GRANULE

Route

ORAL

TE code

Not listed

Application

NDA 219696

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (2)

  • NPNew product exclusivity (3 years)

    Jul 24, 2028

    in 2 yr 2 mo

  • ODE-548Orphan-drug exclusivity (7 years)

    Jul 24, 2032

    in 6 yr 2 mo

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7638536Jul 28, 2027in 1 yr 1 mo
SubstanceProduct
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.